Clinical Trials Browser

fisogatinib × Gastrointestinal × Clear all

NCT02508467 2024-04-12

A Phase 1 Study of Fisogatinib (BLU-554) in Patients With Hepatocellular Carcinoma

Phase 1 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms

NCT04194801 2023-02-06

A Phase Ib/II Study of Fisogatinib(BLU-554) in Subjects With Hepatocellular Carcinoma

Phase 1/2 Completed

26 enrolled 31 charts

Gastrointestinal

Carcinoma, Hepatocellular